Free shipping on all orders over $ 500

SKLB610

Cat. No. M3698

All AbMole products are for research use only, cannot be used for human consumption.

SKLB610 Structure
Size Price Availability Quantity
5mg USD 80  USD80 In stock
10mg USD 140  USD140 In stock
50mg USD 420  USD420 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

SKLB610 potently suppresses human tumor angiogenesis. SKLB610 inhibited angiogenesis-related tyrosine kinase VEGFR2, fibroblast growth factor receptor 2 (FGFR2) and platelet-derived growth factor receptor (PDGFR) at rate of 97%, 65% and 55%, respectively, at concentration of 10μM in biochemical kinase assays. In vitro, SKLB610 showed more selective inhibition of VEGF-stimulated human umbilical vein endothelial cells (HUVECs) proliferation, and this proliferation inhibitory effect was associated with decreased phosphorylation of VEGFR2 and p42/44 mitogen-activated protein kinase (p42/44 MAPK). SKLB610 inhibited the HUVECs capillary-tube formation on Matrigel in vitro and the sub-intestinal vein formation of zebrafish in vivo. Moreover, SKLB610 inhibited a panel of human cancer cells proliferation in a concentration-dependent manner and human non-small cell lung cancer cell line A549 and human colorectal cancer cell line HCT116 were most sensitive to SKLB610 treatment.

Chemical Information
Molecular Weight 415.37
Formula C21H16F3N3O3
CAS Number 1125780-41-7
Solubility (25°C) DMSO
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Cao ZX, et al. Cell Physiol Biochem. SKLB610: a novel potential inhibitor of vascular endothelial growth factor receptor tyrosine kinases inhibits angiogenesis and tumor growth in vivo.

Related FGFR Products
SNIPER(TACC3)-11 

SNIPER(TACC3)-11 is a potent FGFR3-TACC3 degrader.

LY-3076226

LY-3076226 is an antibody drug coupling (ADC) with a cleavable linker targeting FGFR2.

Aprutumab ixadotin

Aprutumab ixadotin is an antibody drug coupling (ADC) with a non-cleavable linker that targets FGFR2.

Gunagratinib

Gunagratinib is an orally active, potent, selective, and irreversible fibroblast growth factor receptor (pan-FGFR) inhibitor for use in cancer research.

SAR-442501

SAR-442501 is a novel anti-FGFR3 monoclonal antibody for studies related to achondroplasia (ACH).

  Catalog
Abmole Inhibitor Catalog




Keywords: SKLB610 supplier, FGFR, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.